Drugs / Tolterodine ER
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01741454 | Nov 2012 → Mar 2018 | ureteral obstruction | University of Wisconsin, Madison | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tolterodine ER | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01741454 ↗ |
| Route | Oral | “4 mg by mouth once a day.” NCT01741454 ↗ |